Details of the Drug Formulaction

General Information of Drug Formulation (ID: F21062)

Formulation Name

Thioguanine 40 mg tablet

Company

GlaxoSmithKline

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Thioguanine	DM7NKEV	Acute lymphocytic leukaemia	2B33.3	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Lactose monohydrate	E00393	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	E00208	11177	lubricant
Stearic acid	E00079	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant

--------------------